Xoma reported $0 in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Ardelyx ARDX:US $ 7.03M 8.1M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Emergent Biosolutions EBS:US $ 817.3M 7.9M
Epizyme EPZM:US $ 231.83M 640K
Life Technologies LIFE:US $ 0M 0M
Macrogenics MGNX:US $ 0 0
Novartis NVS:US $ 24715M 1776M
Novartis NOVN:VX SF 24715M 1776M
Prothena PRTA:US 0 0
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 31.38M 0.46M